Side-by-side comparison of AI visibility scores, market position, and capabilities
Google's YouTube ad-free subscription with background playback and YouTube Music; 100M subscribers growing as anti-ad-blocker enforcement drives conversions from ad-supported viewing.
YouTube Premium is Google's subscription tier for YouTube that removes advertisements from videos, enables background playback (continuing video audio when the screen is off or switching to another app), and provides access to YouTube Music (Google's music streaming service) — offering an ad-free, feature-enhanced YouTube experience for $13.99/month. Part of Google (Alphabet Inc., NASDAQ: GOOGL), YouTube Premium has grown to approximately 100 million subscribers as YouTube's content ecosystem has grown, making it a significant recurring revenue stream alongside YouTube's dominant advertising business.\n\nYouTube Premium's value proposition is primarily ad-free viewing — YouTube's ad load has increased significantly as the platform has expanded advertising, making the ad-free experience increasingly attractive to heavy viewers. Background playback is particularly valued for music and podcast content. YouTube Music inclusion (equivalent to Spotify or Apple Music) adds streaming music at no additional cost, bundling two streaming services in one subscription. YouTube Originals (exclusive content) historically differentiated Premium but Google has largely discontinued new Originals production.\n\nIn 2025, YouTube Premium competes with Spotify and Apple Music for streaming music subscriptions, but its primary competition is against its own free ad-supported tier — YouTube must balance monetizing through Premium subscriptions versus maximizing ad revenue from the much larger free user base. Google has increased enforcement against third-party ad blockers on YouTube in 2023-2024, driving significant Premium subscription growth. YouTube's 2025 strategy focuses on continued anti-ad-blocker measures that push users toward Premium, investing in YouTube TV (live TV streaming service), and growing YouTube Shopping integrations that convert viewer attention into commerce.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.